Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 27 April 2005. doi:10.1136/gut.2004.060533
Gut 2005;54:1136-1145
Copyright © 2005 BMJ Publishing Group Ltd & British Society of Gastroenterology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
gut.2004.060533v1
54/8/1136    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aparicio, T
Right arrow Articles by Lehy, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aparicio, T
Right arrow Articles by Lehy, T

COLON CANCER

Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in ApcMin/+ mice

T Aparicio, L Kotelevets, A Tsocas, J-P Laigneau, I Sobhani, E Chastre, T Lehy

INSERM, U 683, IFR 02, Faculté de Médecine Xavier Bichat, Paris, France

Correspondence to:
Correspondence to:
Dr T Lehy
INSERM U 683, Faculté de Médecine Xavier Bichat, 16 rue Henri Huchard, BP 416, Paris, Cedex 18, F-75870, France; tlehy{at}bichat.inserm.fr


ABSTRACT
Background and aims: Leptin, the product of the ob gene, has been suggested to increase the risk of colon cancer. However, we have shown that although leptin stimulates epithelial cell proliferation it reduces the development of carcinogen induced preneoplastic lesions in the rat colon. Here, we explored the effect of leptin in vitro on proliferation of human colon cancer cells, and in vivo on the growth of HT-29 xenografts in nude mice and the development of intestinal tumours in ApcMin/+ mice.

Methods: Proliferation of HT-29, LoVo, Caco2, and SW 480 cells was assessed in the absence or presence of leptin (20–500 ng/ml) by 3H-thymidine incorporation and cell count. Leptin (800 µg/kg/day) or its vehicle was delivered for four weeks to nude mice, inoculated with HT-29 cells on day 0, and for six weeks to ApcMin/+ mice.

Results: Leptin dose dependently stimulated cell DNA synthesis and growth in all cell lines. In nude mice, leptin caused a 4.3-fold increase in plasma leptin levels compared with pair fed controls. This hyperleptinaemia, despite leptin receptor expression in tumours, did not induce significant variation in tumour volume or weight. Tumour Ki-67 index was even inhibited. In leptin treated ApcMin/+ mice, a 2.4-fold increase in plasma leptin levels did not modify the number, size, or distribution of intestinal adenomas compared with pair fed controls.

Conclusions: Leptin acts as a growth factor on colon cancer cells in vitro but does not promote tumour growth in vivo in the two models tested. These findings do not support a pivotal role for hyperleptinaemia in intestinal carcinogenesis.


Abbreviations: FCS, fetal calf serum; PCR, polymerase chain reaction; BSA, bovine serum albumin; SDS-PAGE, sodium dodecyl sulphate-polyacrylamide gel electrophoresis

Keywords: hormone; carcinogenesis; animal models; cell lines; TdT, terminal deoxynucleotidyl transferase; TUNEL, terminal deoxynucleotidyl transferase mediated dUTP nick end labelling




This article has been cited by other articles:


Home page
EndocrinologyHome page
H. Nave, G. Mueller, B. Siegmund, R. Jacobs, T. Stroh, U. Schueler, M. Hopfe, P. Behrendt, T. Buchenauer, R. Pabst, et al.
Resistance of Janus Kinase-2 Dependent Leptin Signaling in Natural Killer (NK) Cells: A Novel Mechanism of NK Cell Dysfunction in Diet-Induced Obesity
Endocrinology, July 1, 2008; 149(7): 3370 - 3378.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. E. Drew, A. J. Farquharson, S. Padidar, G. G. Duthie, J. G. Mercer, J. R. Arthur, P. C. Morrice, and L. N. Barrera
Insulin, leptin, and adiponectin receptors in colon: regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine
Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G682 - G691.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M. Koda, M. Sulkowska, L. Kanczuga-Koda, E. Surmacz, and S. Sulkowski
Overexpression of the obesity hormone leptin in human colorectal cancer
J. Clin. Pathol., August 1, 2007; 60(8): 902 - 906.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S-N Wang, S-C Chuang, Y-T Yeh, S-F Yang, C-Y Chai, W-T Chen, K-K Kuo, J-S Chen, and K-T Lee
Potential prognostic value of leptin receptor in hepatocellular carcinoma
J. Clin. Pathol., December 1, 2006; 59(12): 1267 - 1271.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. I. Fenton, S. D. Hursting, S. N. Perkins, and N. G. Hord
Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc (Min/+) colon epithelial cell line
Carcinogenesis, July 1, 2006; 27(7): 1507 - 1515.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
E E Frezza, M S Wachtel, and M Chiriva-Internati
Influence of obesity on the risk of developing colon cancer
Gut, February 1, 2006; 55(2): 285 - 291.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & British Society of Gastroenterology